STE
STERIS plc$212.73
+0.51%Live · FMPMay 29, 2026
Market cap
$20.88B
52w range
195.14 – 269.44
P / E
—
EPS
—
Volume
484.76K
Revenue · FY
$5.46B
+6.24% YoY
AI Issuer Brief
Arphra AILoading cached brief…
Peers
- BIIBBiogen Inc.$187.06$27.62B
- PHGKoninklijke Philips N.V.$26.16$24.89B
- DXCMDexCom, Inc.$61.35$23.67B
- DGXQuest Diagnostics Incorporated$192.67$21.33B
- WSTWest Pharmaceutical Services, Inc.$300.68$21.24B
- LHLabcorp Holdings Inc.$255.84$21.06B
- WATWaters Corporation$307.12$18.28B
- ZBHZimmer Biomet Holdings, Inc.$82.90$16.05B
Price change · trailing returns
Live · FMP| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.24% | -0.96% | -1.91% | -15.70% | -20.11% | -16.09% | -12.12% | +6.38% | +12.90% | +206.39% | +10226.70% |
Aftermarket
Live · FMPLast trade
$211.70
751 sh
Bid
$210.00
10 sh
Ask
$222.70
1 sh
Spread
$12.700
Fair value
Football field →Weighted blend
$335.58
+57.75% vs spot
Recommendation
Strong Buy
18 of 19 methods
Method spread
5bull12bear
±5% threshold
Analyst PT consensus: $256.67 (+20.66%)
Total assets
$10.15B
Total debt
$2.2B
Cash & equiv
$171.7M
Operating CF
$1.15B
Free cash flow
$778M
Buybacks
-$211.32M
Analyst view
DB · price_targets + analyst_gradesConsensus target
$256.67
+20.66% upside
Low
$245.00
Median
$260.00
High
$265.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Tradingzacks.com·May 12, 2026
- STERIS plc (STE) Q4 2026 Earnings Call Transcriptseekingalpha.com·May 12, 2026
- STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Yearglobenewswire.com·May 11, 2026
- STERIS Appoints Pierre Boulud to Board of Directorsglobenewswire.com·May 07, 2026
- STERIS Announces Dividend of $0.63 per shareglobenewswire.com·May 05, 2026
- STERIS' Q4 Earnings on Deck: What's in Store for the Stock?zacks.com·May 04, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 Dec 2025 | $1.5B | $192.8M | $1.96 |
| Q2 Sep 2025 | $1.46B | $191.9M | $1.94 |
| Q1 Jun 2025 | $1.39B | $177.4M | $1.79 |
| Q4 Mar 2025 | $1.48B | $145.67M | $1.48 |
| Q3 Dec 2024 | $1.37B | $173.53M | $1.75 |
| Q2 Sep 2024 | $1.33B | $150.03M | $1.51 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
FELDMANN CYNTHIA L director | Sell | 3,098 | $734.88K | Mar 05, 2026 |
Madsen Julia officer: Sr. VP and GM, Life Sciences | Sell | 2,136 | $559.63K | Nov 21, 2025 |
Tamaro Renato officer: V.P. & Corporate Treasurer | Sell | 1,500 | $386.64K | Nov 18, 2025 |
Tamaro Renato officer: V.P. & Corporate Treasurer | Sell | 3,324 | $855.7K | Nov 18, 2025 |
Tamaro Renato officer: V.P. & Corporate Treasurer | Sell | 212 | $54.7K | Nov 18, 2025 |
Zangerle John Adam officer: Sr. VP, Gen Counsel, and Sec. | Sell | 15,000 | $3.98M | Nov 11, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $5.46B | $866.64M | $614.64M | $6.20 | +11.26% |
| FY 2024 | $5.14B | $836.12M | $378.24M | $3.81 | +7.36% |
| FY 2023 | $4.54B | $791.1M | $107.03M | $1.07 | +2.36% |
| FY 2022 | $4.22B | $477.82M | $243.89M | $2.48 | +5.77% |
| FY 2021 | $3.11B | $548.37M | $397.4M | $4.63 | +12.79% |